This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Human Microbiomes in Health and Disease: Strategic Options for Regulatory Science and Healthcare Policy
Published on: Sept 4, 2020
This article describes the human microbiota and microbiomes’ strategic role in personalizing health and disease management, which is rapidly demanding diligent regulatory science and policy action to ascertain confidence and trust among consumers, patients, and healthcare providers. The authors discuss why establishing harmonized processes and standards to better understand the baseline healthy microbiota is essential to the development of strategies for nutrition and clinical applicability. They conclude that, given the complexity of issues, a well-orchestrated, multistakeholder approach is advisable for the best chance of success.
Citation Ruthsatz M, Voisin E, Lima N, D’Hondt K. Human microbiomes in health and disease: Strategic options for regulatory science and healthcare policy. Regulatory Focus. July 2020. Regulatory Affairs Professionals Society.
Download the full resource now
Fill in the form to download the content